Research funding opportunities

Primarily supports clinical trials, and other robustly designed studies that test the efficacy of interventions. The interventions should have the potential to improve patient care or benefit the public. The programme will only support studies where there is sufficient evidence that the intervention might work in man, i.e. that there is ‘proof of concept’.

Funds research about the clinical and cost effectiveness and broader impact of healthcare treatments and tests for NHS users and service providers. The study outcomes should lead to findings that have potential to be of direct benefit to NHS patients.

To support the application of emerging technologies and demonstrate their usefulness and broader applicability within clinics.

Supports work that will deliver findings with practical application, typically through improved healthcare or better healthcare delivery, within three to five years of programme's end.

Funds research that evaluates public health interventions, providing new knowledge on the benefits, costs, acceptability and wider impacts of non-NHS interventions intended to improve health and reduce inequalities in health.

The Rapid Funding Scheme (RFS) offers researchers the opportunity to apply for funds to conduct rapid baseline data collection, as well as other feasibility work, prior to intervention implementation, for time-limited opportunities such as a natural experiment or similar evaluations of a new public health intervention.

Funds health, public health and social care research covering a wide range of health service challenges. The aim of the programme is to fund topics and research methodologies that increase the effectiveness of NHS services, provide value for money and benefit patients.

Funds systematic reviews to identify, evaluate, combine and summarise the findings of all relevant individual studies, to provide decision makers with the best possible information about the effects of tests, treatments and other interventions used in health and social care.

Supports projects which investigate potential therapeutic treatments of Niemann-Pick Disease, Type C (NPC).

Projects should address key questions such as the nature and importance of cardiovascular complications in covid-19 infection, and how they could be prevented; understanding why patients with heart and circulatory diseases are at greater risk of adverse outcomes; the short and longer-term impact of the covid-19 pandemic for people with heart and circulatory diseases; mechanistic insights into individual responses to the covid-19 infection, its effect on the function of the heart and the circulat...